2AEI image
Deposition Date 2005-07-22
Release Date 2006-08-01
Last Version Date 2023-11-15
Entry Detail
PDB ID:
2AEI
Keywords:
Title:
Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]-3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2-pyridinyl]oxy]-benzoic acid
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.52 Å
R-Value Free:
0.29
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII
Gene (Uniprot):F7
Chain IDs:B (auth: H)
Chain Length:254
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII
Gene (Uniprot):F7
Chain IDs:A (auth: L)
Chain Length:152
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Tissue factor
Gene (Uniprot):F3
Chain IDs:C (auth: T)
Chain Length:211
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CGU A GLU GAMMA-CARBOXY-GLUTAMIC ACID
Primary Citation
The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex.
Bioorg.Med.Chem.Lett. 15 4752 4756 (2005)
PMID: 16125385 DOI: 10.1016/j.bmcl.2005.07.059

Abstact

The activated Factor VII/tissue factor complex (FVIIa/TF) plays a key role in the formation of blood clots. Inhibition of this complex may lead to new antithrombotic drugs. An X-ray crystal structure of a fluoropyridine-based FVIIa/TF inhibitor bound in the active site of the enzyme complex suggested that incorporation of substitution at the 5-position of the hydroxybenzoic acid side chain could lead to the formation of more potent inhibitors through interactions with the S1'/S2' pocket.

Legend

Protein

Chemical

Disease

Primary Citation of related structures